Alerts will be sent to your verified email
Verify Email
THEMISMED
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Themis Medicare Ltd. is a research-based pharmaceutical company focusing on Pain Management, Critical Care, and Anti-Infectives. It develops differentiated products for patient benefit.
Themis Medicare major competitors are NGL Fine-Chem, Shree Ganesh Remed., Kopran, Bajaj Healthcare, Everest Organics, Haleos Labs, Nectar Lifesciences.
Market Cap of Themis Medicare is ₹923 Crs.
While the median market cap of its peers are ₹757 Crs.
Themis Medicare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Sep | Sep Dec | ||||||||||||||||
| Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | ||||||||||||||
| Conference Call | Mar Sep | Sep Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
